Literature DB >> 19438129

Post mastectomy adjuvant radiotherapy in breast cancer: a comparision of three hypofractionated protocols.

Abubaker Shahid1, Mohammad Amin Athar, Saeeda Asghar, Tanvir Zubairi, Sohail Murad, Numair Yunas.   

Abstract

OBJECTIVES: To compare three hypofractionated protocols in postmastectomy cancinoma breast in terms of local control, toxicity and work load.
METHODS: A total of three hundred patients suffering from cancer breast stage T2-4, N any were randomized into three arms after mastectomy. All the patients were treated with four fields on Co60 i.e. two tangential portals for chest wall, one anterior supraclavicular and axillary field and a posterior axillary boost and were randomized into three arms i.e. 2700 CGy in 5 fractions (one week) arm A, 3500 CGy in 10 fractions (2 weeks) arm B and 4000 CGy in 15 fractions (3 weeks) arm C. Skin, cardiac, pulmonary and haematological toxicities and lymphoedema were compared in addition to local control and work load.
RESULTS: The locoregional relapses were 11%, 12% and 10% in arms A, B and C respectively. 26%, 24% and 28% patients developed metastatic disease and 17%, 18% and 20% died in the three arms. G3 and G4 skin toxicities were 37%, 28% and 14%. G2 and G3 lymphedoema was 21%, 22% and 27%. Cardiac toxicity was 5%, 6% and 5% while pulmonary toxicity was 4%, 5% and 5% respectively. All the differences except skin toxicity were statistically insignificant. There were no cases of haematological depression or rib fractures.
CONCLUSION: All the three short protocols were equally effective in locoregional disease control and toxicity was also comparable. They were helpful in reducing the work load and can be safely recommended for routine clinical use.

Entities:  

Mesh:

Year:  2009        PMID: 19438129

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  11 in total

1.  A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer.

Authors:  Vassilis Kouloulias; Eftychia Mosa; Anna Zygogianni; Efrosini Kypraiou; John Georgakopoulos; Kalliopi Platoni; Christos Antypas; George Kyrgias; Maria Tolia; Christos Papadimitriou; Amanda Psyrri; George Patatoukas; Maria Dilvoi; Christina Armpilia; Kyriaki Theodorou; Maria-Aggeliki Kalogeridi; Ivelina Beli; John Kouvaris; Nikolaos Kelekis
Journal:  Breast Care (Basel)       Date:  2016-09-28       Impact factor: 2.860

2.  Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up.

Authors:  Hany Eldeeb; Iman Awad; Osman Elhanafy
Journal:  Med Oncol       Date:  2012-02-22       Impact factor: 3.064

3.  5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial.

Authors:  Matthew M Poppe; Zeinab A Yehia; Christopher Baker; Sharad Goyal; Deborah Toppmeyer; Laurie Kirstein; Chunxia Chen; D F Moore; Bruce G Haffty; Atif J Khan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-11       Impact factor: 7.038

4.  Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.

Authors:  Sriram Venigalla; David M Guttmann; Varsha Jain; Sonam Sharma; Gary M Freedman; Jacob E Shabason
Journal:  Clin Breast Cancer       Date:  2018-02-21       Impact factor: 3.225

5.  Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial.

Authors:  Hilde Van Parijs; Geertje Miedema; Vincent Vinh-Hung; Sylvia Verbanck; Nele Adriaenssens; Dirk Kerkhove; Truus Reynders; Daniel Schuermans; Katrien Leysen; Shane Hanon; Guy Van Camp; Walter Vincken; Guy Storme; Dirk Verellen; Mark De Ridder
Journal:  Radiat Oncol       Date:  2012-06-01       Impact factor: 3.481

6.  Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.

Authors:  Imjai Chitapanarux; Pitchayaponne Klunklin; Attapol Pinitpatcharalert; Patumrat Sripan; Ekkasit Tharavichitkul; Wannapha Nobnop; Wimrak Onchan; Somvilai Chakrabandhu; Bongkot Jia-Mahasap; Juntima Euathrongchit; Yutthaphan Wannasopha; Tanop Srisuwan
Journal:  Radiat Oncol       Date:  2019-10-14       Impact factor: 3.481

7.  Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis.

Authors:  Tobias Engel Ayer Botrel; Otávio Clark; Antônio Carlos Lima Pompeo; Francisco Flávio Horta Bretas; Marcus Vinicius Sadi; Ubirajara Ferreira; Rodolfo Borges Dos Reis
Journal:  Core Evid       Date:  2013-03-07

8.  Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.

Authors:  Harijati Versmessen; Vincent Vinh-Hung; Hilde Van Parijs; Geertje Miedema; Mia Voordeckers; Nele Adriaenssens; Guy Storme; Mark De Ridder
Journal:  BMC Cancer       Date:  2012-10-25       Impact factor: 4.430

9.  Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.

Authors:  Mélanie Doré; Bruno Cutuli; Patrice Cellier; Loïc Campion; Magali Le Blanc
Journal:  Radiat Oncol       Date:  2015-08-04       Impact factor: 3.481

10.  A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients.

Authors:  Kartick Rastogi; Sandeep Jain; Aseem Rai Bhatnagar; Sandeep Bhaskar; Shivani Gupta; Neeraj Sharma
Journal:  Asia Pac J Oncol Nurs       Date:  2018 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.